Epigenetic Memory of Vitamin D Supplementation

Launched by POLISH ACADEMY OF SCIENCES · Oct 24, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Epigenetic Memory of Vitamin D Supplementation," is exploring how vitamin D3, a nutrient found in some foods and supplements, can influence our immune system at a cellular level. The researchers want to understand how vitamin D3 affects the way our immune cells remember and respond to various conditions, especially regarding immune system diseases and infections. They will be working with a small group of healthy adults, monitoring various biological changes over time to see how vitamin D3 might help improve immune health.

To participate in this study, individuals must be healthy adults aged 18 to 65 years. However, those who smoke, have a body mass index (BMI) over 28, or have certain health conditions like kidney disease or severe liver problems are not eligible. Participants will have their health tracked closely as the researchers conduct tests and gather information about how vitamin D3 affects their immune cells. This trial is currently looking for volunteers, so if you meet the eligibility criteria and are interested, this could be a great opportunity to contribute to important health research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -Healthy adult (18-65 years)
• Exclusion Criteria:
• • Smoker
• • BMI \> 28 kg/m2
• • History of kidney stones, renal failure or dialysis, hypercalcemia, hypo- or hyperparathyroidism, severe liver disease (cirrhosis), or sarcoidosis or other granulomatous diseases, such as active chronic tuberculosis or Wegener's granulomatosis